Analysing and exploiting the Mantin biases in RC4.

We explore the use of the Mantin biases (Mantin, Eurocrypt 2005) to recover plaintexts from RC4-encrypted traffic. We provide a more fine-grained analysis of these biases than in Mantin's original work. We show that, in fact, the original analysis was incorrect in certain cases: the Mantin biases are sometimes non-existent, and sometimes stronger than originally predicted.

Cluster randomized trials of prescription medicines or prescribing policy: public and general practitioner opinions in Scotland.

Aims: To understand public and general practitioner (GP) opinion on the acceptability of randomized policy design (RPD) studies (cluster randomized trials) of prescription medicines in Scotland.

Methods: We surveyed public opinion on the concept of RPD studies in a sample of 1040 adults to determine acceptability and understand how people feel when changes are made to their medicines. We also surveyed GPs (n = 1034) about the concept of RPD studies as a tool for improving understanding of comparative effectiveness and safety of medicines in the 'usual care' setting.

Periodontitis in non-smoking type 1 diabetic adults: a cross-sectional study.

Aim: To compare levels of periodontitis in non-smoking type 1 diabetic patients and controls.

Material And Methods: Type 1 diabetic patients, aged 20-55 years, were recruited from outpatient clinics at five hospitals in Glasgow, UK. Control subjects were recruited from physiotherapy clinics, using the buddy system and through an advertisement in a free newspaper.

Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial.

Background: Increasingly strong links are being recognized between diabetes, insulin resistance and liver fat accumulation [e.g. nonalcoholic fatty liver disease (NAFLD)].

Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk?

Background: Conventional hormone replacement therapy (HRT) containing conjugated equine oestrogen (CEE) and medroxyprogesterone acetate (MPA) increases triglyceride, C-reactive protein (CRP) and coagulation Factor VII concentrations, potentially explaining their increased coronary heart disease (CHD) and stroke risk.

Objective: To assess the metabolic effects of a continuous combined HRT containing 1 mg oestradiol and 0.5 mg norethisterone or matching placebo.